FDA Approves Durata's Dalvance

The U.S. Food and Drug Administration approved Durata Therapeutics Inc.'s Dalvance antibiotic to treat acute drug-resistant skin infections.



from WSJ.com: US Business http://ift.tt/1oprE55

via IFTTT